Bettina Ryll, Founder of MPN Europe, shared on LinkedIn:
“Listening to Valerie Diane Valeriano at MPNEhubs 2024 on how the microbiome modulates response to immune therapies in Melanoma and her work in the OncoBiome project.
A lot of considerations to turn an observation into something that could become a treatment a scale- and why designer microbiome consortia might be a good concept.
If you want to meet someone passionate about microbiota- you have to meet Valerie Diane Valeriano.”
Article 1: Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
More posts featuring Bettina Ryll.
